Evandro D. Bezerra

1.5k total citations
31 papers, 523 citations indexed

About

Evandro D. Bezerra is a scholar working on Oncology, Hematology and Electrical and Electronic Engineering. According to data from OpenAlex, Evandro D. Bezerra has authored 31 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Hematology and 9 papers in Electrical and Electronic Engineering. Recurrent topics in Evandro D. Bezerra's work include CAR-T cell therapy research (17 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Evandro D. Bezerra is often cited by papers focused on CAR-T cell therapy research (17 papers), Acute Myeloid Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Evandro D. Bezerra collaborates with scholars based in United States, Brazil and South Africa. Evandro D. Bezerra's co-authors include David G. Maloney, Ana Cordeiro, Merav Bar, Cameron J. Turtle, Jenna Voutsinas, Joshua A. Hill, Qian Wu, Alexandre V. Hirayama, Mohamed L. Sorror and Stephanie J. Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Evandro D. Bezerra

27 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evandro D. Bezerra United States 9 393 117 95 89 87 31 523
Elise McCormack United States 4 351 0.9× 91 0.8× 104 1.1× 48 0.5× 135 1.6× 8 565
Huiwen Jiang China 11 367 0.9× 122 1.0× 105 1.1× 62 0.7× 102 1.2× 27 533
Chunrong Tong China 11 337 0.9× 104 0.9× 86 0.9× 61 0.7× 69 0.8× 50 450
Martina Pennisi Italy 12 520 1.3× 88 0.8× 134 1.4× 153 1.7× 87 1.0× 29 612
Kotaro Miyao Japan 11 215 0.5× 83 0.7× 73 0.8× 46 0.5× 85 1.0× 34 377
Ana Cordeiro Brazil 5 332 0.8× 35 0.3× 89 0.9× 80 0.9× 68 0.8× 21 400
Aimee C. Talleur United States 13 399 1.0× 105 0.9× 100 1.1× 47 0.5× 85 1.0× 47 583
Christine Dehner United States 11 402 1.0× 153 1.3× 74 0.8× 71 0.8× 52 0.6× 19 520
Carrie Yuen United States 7 284 0.7× 77 0.7× 102 1.1× 32 0.4× 70 0.8× 19 470
Alessandro Crotta United States 7 273 0.7× 99 0.8× 43 0.5× 44 0.5× 26 0.3× 26 369

Countries citing papers authored by Evandro D. Bezerra

Since Specialization
Citations

This map shows the geographic impact of Evandro D. Bezerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evandro D. Bezerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evandro D. Bezerra more than expected).

Fields of papers citing papers by Evandro D. Bezerra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evandro D. Bezerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evandro D. Bezerra. The network helps show where Evandro D. Bezerra may publish in the future.

Co-authorship network of co-authors of Evandro D. Bezerra

This figure shows the co-authorship network connecting the top 25 collaborators of Evandro D. Bezerra. A scholar is included among the top collaborators of Evandro D. Bezerra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evandro D. Bezerra. Evandro D. Bezerra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qiuhong, Evandro D. Bezerra, Hannah Choe, et al.. (2025). Oral Azacitidine Use after Stem Cell Transplantation for Myeloid Malignancies: A Single Center Experience. Transplantation and Cellular Therapy. 31(2). S429–S430.
2.
Silberman, Pedro C., Yazeed Sawalha, Beth Christian, et al.. (2024). Secondary myeloid malignancy after CAR T cell therapy for non-Hodgkin lymphoma (NHL).. Journal of Clinical Oncology. 42(16_suppl). 7033–7033. 2 indexed citations
3.
Zhao, Qiuhong, Chenyu Lin, Monalisa Ghosh, et al.. (2024). Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis. Blood Advances. 9(1). 170–175. 12 indexed citations
4.
Siegler, Elizabeth L., et al.. (2024). Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma. Frontiers in Pediatrics. 11. 1305657–1305657. 10 indexed citations
5.
Cordeiro, Ana, et al.. (2024). Late events after anti-CD19 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. Frontiers in Oncology. 14. 1404351–1404351. 2 indexed citations
6.
Zhao, Qiuhong, Timothy Voorhees, Nathan Denlinger, et al.. (2024). Association between post-CART terminal complement complex (TCC) levels and clinically significant immune effector cell–associated neurotoxicity syndrome (ICANS).. Journal of Clinical Oncology. 42(16_suppl). 7036–7036. 1 indexed citations
7.
Voorhees, Timothy, Evandro D. Bezerra, Nathan Denlinger, Samantha Jaglowski, & Marcos de Lima. (2024). SOHO State of the Art Updates and Next Questions Updates on Building Your CAR-T Cell Program. Clinical Lymphoma Myeloma & Leukemia. 24(10). 649–652. 1 indexed citations
8.
Voorhees, Timothy, Ying Huang, Nathan Denlinger, et al.. (2024). Siltuximab Prophylaxis Prior to Standard of Care CD19 Directed Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: Interim Results from a Phase I Clinical Trial. Transplantation and Cellular Therapy. 30(2). S355–S356. 3 indexed citations
9.
Shah, Manan, et al.. (2023). Promises and challenges of a decentralized CAR T-cell manufacturing model. SHILAP Revista de lepidopterología. 2. 1238535–1238535. 24 indexed citations
10.
Merryman, Reid W., Evandro D. Bezerra, Timothy Voorhees, et al.. (2023). Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma. Blood. 142(Supplement 1). 3511–3511. 1 indexed citations
11.
Johnson, Isla McKerrow, Evandro D. Bezerra, Kristen McCullough, et al.. (2022). Cardiac events in patients with acute myeloid leukemia treated with venetoclax combined with hypomethylating agents. Blood Advances. 6(17). 5227–5231. 16 indexed citations
12.
Bezerra, Evandro D., Giacomo Coltro, Terra L. Lasho, et al.. (2020). Landscape of RAS pathway mutations in patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a study of 461 molecularly annotated patients. Leukemia. 35(2). 644–649. 7 indexed citations
13.
Morsink, Linde M., Megan Othus, Evandro D. Bezerra, et al.. (2020). Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML. Leukemia. 34(6). 1577–1587. 24 indexed citations
14.
15.
Mullane, Erin, Ana Cordeiro, Evandro D. Bezerra, et al.. (2019). Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy. Biology of Blood and Marrow Transplantation. 26(1). 34–43. 108 indexed citations
16.
Bezerra, Evandro D., Linde M. Morsink, Megan Othus, et al.. (2019). Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measurable Residual Disease. Blood. 134(Supplement_1). 321–321. 1 indexed citations
17.
Cordeiro, Ana, Evandro D. Bezerra, Alexandre V. Hirayama, et al.. (2019). Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells. Biology of Blood and Marrow Transplantation. 26(1). 26–33. 246 indexed citations
18.
Cordeiro, Ana, Evandro D. Bezerra, Joshua A. Hill, et al.. (2018). Late Effects of CD19-Targeted CAR-T Cell Therapy. Blood. 132(Supplement 1). 223–223. 11 indexed citations
19.
Bezerra, Evandro D., et al.. (2016). Splenic diffuse red-pulp small B-cell lymphoma associated with hepatitis B virus: a report of two cases. Sao Paulo Medical Journal. 134(4). 359–365. 4 indexed citations
20.
Almeida, João Nóbrega de, Karim Yaqub Ibrahim, Gilda Maria Bárbaro Del Negro, et al.. (2015). Rhizopus arrhizus and Fusarium solani Concomitant Infection in an Immunocompromised Host. Mycopathologia. 181(1-2). 125–129. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elise McCormack Breakdown of academic impact, for papers by Huiwen Jiang Breakdown of academic impact, for papers by Chunrong Tong Breakdown of academic impact, for papers by Martina Pennisi Breakdown of academic impact, for papers by Kotaro Miyao Breakdown of academic impact, for papers by Ana Cordeiro Breakdown of academic impact, for papers by Aimee C. Talleur Breakdown of academic impact, for papers by Christine Dehner Breakdown of academic impact, for papers by Carrie Yuen Breakdown of academic impact, for papers by Alessandro Crotta
Rankless by CCL
2026